Overview & Mechanism
Activates the GPR54 (KISS1R) receptor on GnRH neurons, stimulating pulsatile GnRH release and downstream LH/FSH secretion, regulating puberty and reproduction.
Research Dosage
1–5 mg/week
Subcutaneous injection
Once weekly
4–8 weeks
Reconstitution & Storage
Reconstitute per vial concentration with bacteriostatic water.
Lyophilized: −20 °C. Reconstituted: refrigerate 2–8 °C, use within 28–30 days.
Safety & Side Effects
Research compound; well tolerated in studies. Affects reproductive hormone axis.
Studies
Kisspeptin and reproductive hormone axis
Kisspeptin stimulated LH release in healthy men and women, confirming its role as a key regulator of reproductive function.
Read studyReferences
Research Use Only
This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.